Supporting policies and regulations to reduce childhood obesity including promoting breastfeeding

Supporting policies and regulations to reduce childhood obesity including promoting breastfeeding

WHO/Thailand
© Credits

Overview

The Control of Marketing of Infant and Young Child Food Act is in line with the International Code of Marketing of Breast-milk Substitutes adopted in 1981 and subsequent resolutions endorsed by the World Health Assembly. Thailand now joins 135 other countries around the world that have national laws to protect breastfeeding. By passing this law, the government has demonstrated its strong commitment to protect the health and development of Thai children and future prosperity of the nation.

 

Thailand’s new law is a vital tool and an important step towards reaching the global target of 50% exclusive breastfeeding upto 6 months of age by 2025. WHO commends the Ministry of Public Health and all partners for their efforts and reassure of WHO’s full support to promote breastfeeding and end inappropriate promotion of foods for young children.

Key facts

Almost 1 out of 5 students was overweight (17.1%)
Only 1 out of 3 students ate vegetable regularly (32.5%)
More
than half of student drank carbonated soft drink regularly (56.1%)
More
than half of student had sedentary behavior (56.3%)

Multimedia

Featured publications

WHO consultation on the use of broadly neutralizing antibodies for postnatal prophylaxis against the vertical transmission of HIV: meeting report, 22–23 May and 25 November 2024

Building on growing momentum from multiple stakeholders, this report summarizes the proceedings from a consultation held to convene a multidisciplinary...

The role of the health sector in supporting parents and caregivers to meet their parenting potential

Supporting parents and caregivers requires a whole-of-society approach, with coordinated responses from the health, education, social services, private...

Paediatric drug optimization for epilepsy: meeting report, 1-2 July 2025

The PADO for epilepsy exercise aimed to support the identification of short- and long term priorities for epilepsy medicines for the paediatric age group,...

Towards closing the gap in access to child-friendly formulations of essential medicines

Over four years, under the framework of GAP-f, WHO comprehensively reviewed formulations of medicines listed on the EMLc to inform the 2023 and 2025...

Related activities